Pharma aids in Singapore manufacturing growth

Singapore's manufacturing industry expanded in June, the second time in as many months, with a boost from pharma output. The Purchasing Managers' Index, a leading indicator of manufacturing activity, turned positive in May for the first time in nine months, standing at 51.2. The trend continued in June, with a reading of 51.1. A reading above 50 indicates expansion, according to an announcement from Contact Singapore, an alliance of the Singapore Economic Development Board and Ministry of Manpower.

"The biomedical manufacturing sector expanded 120.4 percent year on year in May, thanks to a 138.6 percent leap in pharmaceutical output," the announcement says. A switch to higher-value patented drug compounds following U.S. approvals drove the increase, with help from a low base last May.

Electronics and aerospace manufacturing were also drivers.

- here's the release

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.